Clinical findings of patients with hyperammonemia affected by urea cycle disorders with hepatic encephalopathy
- 30 September 2022
- journal article
- research article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 82 (8), 771-787
- https://doi.org/10.1002/jdn.10229
Abstract
Urea cycle disorders (UCD) are a group of genetic diseases caused by deficiencies in the enzymes and transporters involved in the urea cycle. The impairment of the cycle results in ammonia accumulation, leading to neurological dysfunctions and poor outcomes to affected patients. The aim of this study is to investigate and describe UCD patients' principal clinical and biochemical presentations to support professionals on urgent diagnosis and quick management, aiming better outcomes for patients. We explored medical records of 30 patients diagnosed in a referral center from Brazil to delineate UCD clinical and biochemical profile. Patients demonstrated a range of signs and symptoms, such as altered levels of consciousness, acute encephalopathy, seizures, progressive loss of appetite, vomiting, coma, and respiratory distress, in most cases combined with high levels of ammonia, which is an immediate biomarker, leading to a UCD suspicion. The most prevalent UCD detected were ornithine transcarbamylase deficiency, followed by citrullinemia type 1, hyper-argininemia, carbamoyl phosphate synthase 1 deficiency, and argininosuccinic aciduria. Clinical symptoms were highly severe, being the majority developmental and neurological disabilities, with 20% of death rate. Laboratory analysis revealed high levels of ammonia (mean +/- SD: 860 +/- 470 mu mol/L; reference value: <= 80 mu mol/L), hypoglycemia, metabolic acidosis, and high excretion of orotic acid in the urine (except in carbamoyl phosphate synthetase 1 [CPS1] deficiency). We emphasize the need of urgent identification of UCD clinical and biochemical conditions, and immediate measurement of ammonia, to enable the correct diagnosis and increase the chances of patients' survival, minimizing neurological and psychomotor damage caused by hepatic encephalopathy.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 51 references indexed in Scilit:
- The incidence of urea cycle disordersMolecular Genetics and Metabolism, 2013
- Argininosuccinate lyase deficiencyGenetics in Medicine, 2012
- High urgency liver transplantation in ornithine transcarbamylase deficiency presenting with acute liver failurePediatric Transplantation, 2011
- N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatmentThe Application of Clinical Genetics, 2011
- Ammonia toxicity and its prevention in inherited defects of the urea cycleDiabetes, Obesity and Metabolism, 2009
- NFκB in the mechanism of ammonia‐induced astrocyte swelling in cultureJournal of Neurochemistry, 2008
- Astrocytic control of glutamatergic activity: astrocytes as stars of the showTrends in Neurosciences, 2004
- Ammonia Prevents Activation of NMDA Receptors by Glutamate in Rat Cerebellar Neuronal CulturesEuropean Journal of Neuroscience, 1995
- Acute ammonia toxicity is mediated by the NMDA type of glutamate receptorsFEBS Letters, 1992
- Prospective treatment of urea cycle disordersThe Journal of Pediatrics, 1991